Japanese pharma firm Eisai invests largest in RecoMed, a South African health tech company.

Japanese pharma firm Eisai invests in South African health tech company RecoMed, marking the largest funding round for the platform. The investment will be used to expand the business, particularly in oncology and neurology, and create a digital patient healthcare journey. RecoMed connects practitioners, patients, and other stakeholders in the healthcare ecosystem, managing over 100,000 bookings monthly.

March 06, 2024
3 Articles

Further Reading